ArticleBMC psychiatry2026
Influence of BDNF rs10835210 on right parahippocampal volume and its related cognitive function in first- and multiple-episode bipolar disorder.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundThe brain-derived neurotrophic factor (BDNF) polymorphism rs10835210 has been implicated in bipolar disorder, but its effects on brain morphology and cognition remain unclear.
methodsA total of 43 first-episode mania patients (FEM), 110 multiple-episode mania patients (MEM) and 80 healthy controls were enrolled in our study. We investigated the impact of BDNF rs10835210 on hippocampal and parahippocampal volumes, and also the Cambridge Neuropsychological Test Automated Battery.
resultsWe found a significant interaction between BDNF genotype and diagnosis affecting the volume of the right parahippocampus as well as cognitive measures of memory and attention functions. Specifically, risk A allele carriers exhibited reduced right parahippocampal volumes in both FEM (p < 0.001) and MEM (p = 0.044) groups; however, the risk A allele was associated with declines in memory and attention functions exclusively in FEM patients (p < 0.05). Furthermore, we demonstrated that lower right parahippocampal volume was correlated with worse attention function in A allele carriers among FEM (r = 0.341, p = 0.025).
conclusionsThis is the first study to demonstrate that BDNF rs10835210 is linked to right parahippocampal volume reductions across illness stages and to parahippocampus-dependent cognitive deficits specifically in FEM. These findings highlight rs10835210 as a candidate marker of neuroimaging alterations and early cognitive dysfunction in bipolar disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.